Ftse Mib
34.189,47
-0,54%
DAX
18.504,89
-0,51%
S&P 500
5.631,22
0,28%
NASDAQ
18.472,57
0,40%
Bitcoin
62.978,12
-2,89%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ ALX Oncology Holdings Inc (ALXO) ALX Oncology Holdings Inc (ALXO) Notizie

ALXO

ALX Oncology (ALXO)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ALXO
DataOraFonteTitoloSimboloCompagnia
10/12/202004:25GlobeNewswire Inc.ALX Oncology Announces Pricing of Upsized Public Offering of Common StockNASDAQ:ALXOALX Oncology Holdings Inc
07/12/202022:07GlobeNewswire Inc.ALX Oncology Announces Proposed Public Offering of Common StockNASDAQ:ALXOALX Oncology Holdings Inc
07/12/202022:04Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:ALXOALX Oncology Holdings Inc
07/12/202016:00GlobeNewswire Inc.ALX Oncology Announces Updated Data from ASPEN-01, the Ongoing Phase 1b Study of ALX148, Showing Robust, Durable Activity in ...NASDAQ:ALXOALX Oncology Holdings Inc
07/12/202013:00GlobeNewswire Inc.ALX Oncology Announces Updates on Planned ALX148 Phase 2 Head and Neck Cancer StudiesNASDAQ:ALXOALX Oncology Holdings Inc
24/11/202013:00GlobeNewswire Inc.ALX Oncology Announces December 2020 Virtual Investor Conference ParticipationNASDAQ:ALXOALX Oncology Holdings Inc
12/11/202022:39Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ALXOALX Oncology Holdings Inc
12/11/202022:21Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ALXOALX Oncology Holdings Inc
12/11/202022:05GlobeNewswire Inc.ALX Oncology Reports Third Quarter 2020 Financial Results and Provides Clinical Development and Operational HighlightsNASDAQ:ALXOALX Oncology Holdings Inc
09/11/202014:10GlobeNewswire Inc.ALX Oncology Announces New Data from ASPEN-01, the Phase 1b Study of ALX148, Showing Promising Initial Clinical Responses in...NASDAQ:ALXOALX Oncology Holdings Inc
05/11/202013:00GlobeNewswire Inc.ALX Oncology to Present ALX148 Clinical Data at the 62nd American Society of Hematology (ASH) Annual MeetingNASDAQ:ALXOALX Oncology Holdings Inc
02/11/202013:00GlobeNewswire Inc.ALX Oncology Announces November 2020 Virtual Investor Conference ParticipationNASDAQ:ALXOALX Oncology Holdings Inc
28/10/202012:00GlobeNewswire Inc.ALX Oncology Announces First Patient Dosed in ASPEN-02, a Phase 1/2 Study of ALX148 in Combination with Azacitidine in Patien...NASDAQ:ALXOALX Oncology Holdings Inc
14/10/202022:25GlobeNewswire Inc.ALX Oncology to Present ALX148 Clinical Data at the Society for Immunotherapy of Cancer (SITC) 35th Anniversary Annual Meetin...NASDAQ:ALXOALX Oncology Holdings Inc
06/10/202013:00GlobeNewswire Inc.ALX Oncology Names Leading Oncology Experts to Scientific Advisory BoardNASDAQ:ALXOALX Oncology Holdings Inc
01/10/202016:02Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:ALXOALX Oncology Holdings Inc
22/09/202014:06Dow Jones NewsALX Oncology, Merck to Collaborate on Head and Neck Cancer Treatment TrialsNASDAQ:ALXOALX Oncology Holdings Inc
22/09/202013:00GlobeNewswire Inc.ALX Oncology to Collaborate with Merck on Phase 2 Immuno-Oncology Studies Evaluating ALX148, Targeting CD47, in Combination w...NASDAQ:ALXOALX Oncology Holdings Inc
17/09/202013:00GlobeNewswire Inc.ALX Oncology Added to Russell 2000® and 3000® IndexesNASDAQ:ALXOALX Oncology Holdings Inc
08/09/202013:00GlobeNewswire Inc.ALX Oncology Announces Participation at Upcoming Investor ConferencesNASDAQ:ALXOALX Oncology Holdings Inc
27/08/202022:05GlobeNewswire Inc.ALX Oncology Reports Second Quarter 2020 Financial Results and Provides Operational and Clinical HighlightsNASDAQ:ALXOALX Oncology Holdings Inc
29/07/202022:35Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ALXOALX Oncology Holdings Inc
22/07/202022:19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXOALX Oncology Holdings Inc
22/07/202022:16Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)NASDAQ:ALXOALX Oncology Holdings Inc
21/07/202022:05GlobeNewswire Inc.ALX Oncology Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additio...NASDAQ:ALXOALX Oncology Holdings Inc
17/07/202002:39GlobeNewswire Inc.ALX Oncology Announces Pricing of Initial Public OfferingNASDAQ:ALXOALX Oncology Holdings Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ALXO

La tua Cronologia

BIT
P1R1V6
BNP Paribas Issuance
NASDAQ
PENX
COIN
FETUSD
Fetch
NASDAQ
GAINL
Gladstone Investment
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network